News FDA Clears Ranibizumab for Diabetic Retinopathy With DME by Medscape • 2015/02/07 • 0 Comments Ranibizumab for diabetic retinopathy with DME had breakthrough therapy designation and was reviewed under the agency's priority review program. FDA Approvals Full Story →